TITLE:
A Study of Mircera for the Treatment of Anemia in Dialysis Patients

CONDITION:
Anemia

INTERVENTION:
epoetin

SUMMARY:

      This study will assess the efficacy and safety of Mircera given intravenously in the
      treatment of renal anemia in chronic kidney disease patients on dialysis who are not
      currently receiving epoetin or any other erythropoietic substance. The anticipated time on
      study treatment is 1-2 years and the target sample size is 100-500 individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  adult patients >=18 years of age;

          -  chronic renal anemia;

          -  dialysis therapy for at least 2 weeks before screening.

        Exclusion Criteria:

          -  women who are pregnant, breastfeeding or using unreliable birth control methods;

          -  administration of any investigational drug within 4 weeks before screening.
      
